Mednet Logo
CommunityNeurology

What would be the main indications for opting for biosimilars over an original biologic, outside of insurance barriers?

Are there any instances where you would prefer a biosimilar rather than the reference product?
Community PollStarted

What concerns do you have regarding prescribing biosimilars?

40 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet Member
Rheumatology · Arthritis and Rheumatism Associates, P.C.
Answered on

A timely question, as we head to 2023! The only reason to use biosimilars is for the broad purpose of resource stewardship. There isn't a medical reason to prefer a biosimilar over a reference product (or vice versa), because if a product were found to have a significantly different therapeutic effe...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Rheumatology · Northwestern University - The Feinberg School of Medicine
Answered on

For those interested, there is an upcoming webinar by the Arthritis Foundation discussing the usage of biosimilars in inflammatory arthritis. It is on 11/9/2022, 6-7PM ET. Further details at the link below:

https://www.arthritis.org/events/webinars/upcoming-webinars

This may provide further informat...

Join for free or sign in to see the full answer